GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Progressive Care Inc (OTCPK:RXMD) » Definitions » ROE %

RXMD (Progressive Care) ROE % : -171.63% (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Progressive Care ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Progressive Care's annualized net income for the quarter that ended in Jun. 2024 was $-37.10 Mil. Progressive Care's average Total Stockholders Equity over the quarter that ended in Jun. 2024 was $21.62 Mil. Therefore, Progressive Care's annualized ROE % for the quarter that ended in Jun. 2024 was -171.63%.

The historical rank and industry rank for Progressive Care's ROE % or its related term are showing as below:

RXMD' s ROE % Range Over the Past 10 Years
Min: -509.38   Med: 13.84   Max: Negative Equity
Current: -113.11

During the past 13 years, Progressive Care's highest ROE % was Negative Equity%. The lowest was -509.38%. And the median was 13.84%.

RXMD's ROE % is ranked worse than
93.38% of 619 companies
in the Healthcare Providers & Services industry
Industry Median: 5.03 vs RXMD: -113.11

Progressive Care ROE % Historical Data

The historical data trend for Progressive Care's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progressive Care ROE % Chart

Progressive Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - Negative Equity -147.49 -

Progressive Care Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -207.02 -29.26 -197.45 -5.63 -171.63

Competitive Comparison of Progressive Care's ROE %

For the Pharmaceutical Retailers subindustry, Progressive Care's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Progressive Care's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Progressive Care's ROE % distribution charts can be found below:

* The bar in red indicates where Progressive Care's ROE % falls into.



Progressive Care ROE % Calculation

Progressive Care's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=0/( (7.618+26.564)/ 2 )
=0/17.091
=0.00 %

Progressive Care's annualized ROE % for the quarter that ended in Jun. 2024 is calculated as

ROE %=Net Income (Q: Jun. 2024 )/( (Total Stockholders Equity (Q: Mar. 2024 )+Total Stockholders Equity (Q: Jun. 2024 ))/ count )
=-37.104/( (26.257+16.981)/ 2 )
=-37.104/21.619
=-171.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2024) net income data. ROE % is displayed in the 30-year financial page.


Progressive Care  (OTCPK:RXMD) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=-37.104/21.619
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-37.104 / 53.908)*(53.908 / 35.1125)*(35.1125 / 21.619)
=Net Margin %*Asset Turnover*Equity Multiplier
=-68.83 %*1.5353*1.6242
=ROA %*Equity Multiplier
=-105.67 %*1.6242
=-171.63 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=-37.104/21.619
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-37.104 / -37.104) * (-37.104 / 1.972) * (1.972 / 53.908) * (53.908 / 35.1125) * (35.1125 / 21.619)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * -18.8154 * 3.66 % * 1.5353 * 1.6242
=-171.63 %

Note: The net income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Progressive Care ROE % Related Terms

Thank you for viewing the detailed overview of Progressive Care's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Progressive Care Business Description

Traded in Other Exchanges
N/A
Address
400 Ansin Boulevard, Suite A, Hallandale Beach, FL, USA, 33009
Progressive Care Inc is a personalized healthcare services and technology company that provides prescription pharmaceutical services, risk management, and data analytics to healthcare organizations and providers. The company through its wholly-owned subsidiary Pharmco, provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, and health practice risk management. It also offers certain disease testing and vaccinations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian, and Russian.
Executives
Charles M. Fernandez director, 10 percent owner, officer: Chairman & CEO C/O FAIRHOLME CAPITAL MANAGEMENT, L.L.C., 4400 BISCAYNE BOULEVARD, 9TH FLOOR, MIAMI FL 33137
Rodney Barreto director, 10 percent owner 460 MARQUESA DRIVE, CORAL GABLES FL 33156
Pamela M Roberts officer: CHIEF OPERATING OFFICER 1540 NW 203 ST, MIAMI FL 33169
Pedro Rodriguez director 258 NE 27TH STREET, MIAMI FL 33137
Birute Norkute officer: Chief Operating Officer 2311 NE 174TH ST, MIAMI FL 33160
Alan Jay Weisberg officer: CHIEF FINANCIAL OFFICER 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Cecile Munnik officer: CFO 400 ANSIN BLVD SUITE A, HALLANDALE BEACH FL 33009
Joseph Ziegler director 1051 HILLSBORO MILE, PH2, HILLSBORO BEACH FL 33062
Jervis Hough director 6053 BARTAM COVE, DULUTH GA 30097
Shital P Parikh director, officer: Chief Operating Officer 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169
Vernon Watson officer: Chief Executive Officer 1111 PARK CENTER BLVD., SUITE 202, MIAMI GARDENS FL 33169
Armen Karapetyan 10 percent owner 17395 NORTH BAY ROAD, SUITE 102, SUNNY ISLES BEACH FL 33160
Avraham A. Friedman director, 10 percent owner, officer: Chief Executive Officer C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162
Andy Subachan director, 10 percent owner, officer: Chief Operating Officer C/O PROGRESSIVE CARE INC., 901 N. MIAMI BEACH BLVD., SUITE 1, N. MIAMI BEACH FL 33162
Buddy Young director, 10 percent owner, officer: President, CEO, CFO, Chairman